Lloyd George W., EVP of Investments and CLO at Royalty Pharma plc ($RPRX), sold shares on the open market 11 times in the last year, totaling $13.8 million. His most recent sale occurred on December 18, 2025. These sales rank 892nd among 11,678 insiders, exceeding the average sale amount of $8.6 million across 6.4 transactions. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 17, 2025 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | S | Class A Ordinary Shares | 79346 | $38.57 | 810,569.1900 | 566,754,000 | 8.92% | 0.01% |
| Dec. 18, 2025 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | S | Class A Ordinary Shares | 30654 | $38.50 | 779,915.1900 | 566,754,000 | 3.78% | 0.01% |
| Dec. 3, 2025 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | S | Class A Ordinary Shares | 110000 | $39.77 | 889,915.1900 | 566,754,000 | 11.00% | 0.02% |
| Nov. 19, 2025 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | S | Class A Ordinary Shares | 2470 | $39.01 | 999,915.1900 | 566,754,000 | 0.25% | 0.00% |
| Nov. 19, 2025 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | S | Class A Ordinary Shares | 230 | $39.03 | 999,915.1900 | 566,754,000 | 0.02% | 0.00% |
| Nov. 19, 2025 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | S | Class A Ordinary Shares | 2770 | $38.29 | 1,000,145.1900 | 566,754,000 | 0.28% | 0.00% |
| Nov. 19, 2025 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | S | Class A Ordinary Shares | 47798 | $38.28 | 1,004,543.1900 | 566,754,000 | 4.54% | 0.01% |
| Nov. 19, 2025 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | S | Class A Ordinary Shares | 4628 | $39.01 | 999,915.1900 | 566,754,000 | 0.46% | 0.00% |
| Nov. 19, 2025 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | S | Class A Ordinary Shares | 47401 | $38.28 | 1,004,514.1900 | 566,754,000 | 4.51% | 0.01% |
| Nov. 19, 2025 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | S | Class A Ordinary Shares | 4599 | $39.01 | 999,915.1900 | 566,754,000 | 0.46% | 0.00% |
| Nov. 19, 2025 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | S | Class A Ordinary Shares | 25530 | $38.28 | 1,002,385.1900 | 566,754,000 | 2.48% | 0.00% |
| Nov. 5, 2025 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | A | Class A Ordinary Shares | 6168 | $0.00 | 1,135,341.1900 | 566,754,000 | 0.55% | 0.00% |
| Aug. 6, 2025 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | A | Class A Ordinary Shares | 3696 | $0.00 | 1,129,173.1900 | 594,108,000 | 0.33% | 0.00% |
| Aug. 8, 2025 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | G | LP interests in RPI US Partners 2019, LP | 8500 | $0.00 | 752,732.0000 | 594,108,000 | 1.12% | 0.00% |
| May 16, 2025 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | A | Class E Ordinary Shares | 1944471 | $0.00 | 1,944,471.0000 | 594,108,000 | 9999.99% | 0.33% |
| May 8, 2025 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | A | Class A Ordinary Shares | 48646 | $0.00 | 1,125,477.1900 | 594,108,000 | 4.52% | 0.01% |
| Aug. 12, 2024 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | G | LP interests in RPI US Partners 2019, LP | 7920 | $0.00 | 408,232.0000 | 602,900,000 | 1.90% | 0.00% |
| Nov. 13, 2023 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | C | LP interests in RPI US Partners 2019, LP | 10000 | $0.00 | 416,152.0000 | 437,972,000 | 2.35% | 0.00% |
| Nov. 13, 2023 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | C | Class A Ordinary Shares | 50000 | $0.00 | 1,076,831.0000 | 437,972,000 | 4.87% | 0.01% |
| Nov. 13, 2023 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | C | Class A Ordinary Shares | 100000 | $0.00 | 1,076,831.0000 | 437,972,000 | 10.24% | 0.02% |
| Nov. 13, 2023 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | C | LP interests in RPI US Partners 2019, LP | 5000 | $0.00 | 416,152.0000 | 437,972,000 | 1.19% | 0.00% |
| Aug. 8, 2023 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | G | LP interests in RPI US Partners 2019, LP | 5555 | $0.00 | 431,152.0000 | 437,972,000 | 1.27% | 0.00% |
| June 6, 2023 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | S | Class A Ordinary Shares | 79099 | $33.82 | 926,831.0000 | 437,972,000 | 7.86% | 0.02% |
| June 5, 2023 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | S | Class A Ordinary Shares | 19215 | $33.54 | 1,005,930.0000 | 437,972,000 | 1.87% | 0.00% |
| June 2, 2023 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | S | Class A Ordinary Shares | 1686 | $33.54 | 1,025,145.0000 | 437,972,000 | 0.16% | 0.00% |
| June 2, 2023 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | S | Class A Ordinary Shares | 92221 | $33.65 | 926,831.0000 | 437,972,000 | 9.05% | 0.02% |
| March 28, 2023 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | S | Class A Ordinary Shares | 100000 | $37.06 | 1,131,831.0000 | 437,972,000 | 8.12% | 0.02% |
| March 29, 2023 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | S | Class A Ordinary Shares | 12779 | $37.03 | 1,119,052.0000 | 437,972,000 | 1.13% | 0.00% |
| Feb. 23, 2023 | Royalty Pharma plc | $RPRX | Lloyd George W. | EVP, Investments & CLO | S | Class A Ordinary Shares | 25000 | $37.27 | 1,231,831.0000 | 437,972,000 | 1.99% | 0.01% |